Oncology
 |
|
26 march 2020 09:02:33 |
| MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia (Future Oncology) |
|
Tweet Future Oncology, Ahead of Print. |
| 194 viewsCategory: Oncology |
 Mood disorders and outcomes in lung cancer patients undergoing surgery: a brief summery (Future Oncology)OCEAN: a randomized Phase III study of melphalan flufenamide + dexamethasone to treat relapsed refractory multiple myeloma (Future Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
